ghk-cu - Research Peptide Reduces fine lines GHK-CU

GHK-CU pairs well with several compounds commonly used in research settings

DSIP has a very short plasma half-life, with effects beginning within 10-30 minutes of subcutaneous injection for most users

Some of the most common areas being investigated include: Skin appearance and texture research Collagen and elastin signaling pathways Tissue regeneration studies Hair and scalp research Cellular repair mechanisms Healthy aging investigations These research areas are the reason GHK-CU benefits continue to attract significant attention among scientists and researchers

The July 2026 FDA PCAC review also shows that Epitalon remains part of an active regulatory conversation around compounded peptide access

The process is identical to other peptides with one key difference: NAD+ is dosed in milligrams (not micrograms), so the math works a little differently